PRINCETON, N.J. & NEW YORK–(BUSINESS WIRE)–The Bristol-Myers Squibb-Pfizer Alliance today announced the initiation of a new randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly...
– The Phase 3 BE READY study, evaluating the efficacy and safety of bimekizumab versus placebo in adults with moderate-to-severe chronic plaque psoriasis, met all primary and ranked secondary endpoints(1) – UCB plans to submit applications to regulatory...
Zealand Pharma completes Phase 3 clinical program for HypoPal® rescue pen, initiates a new Phase 2 clinical proof of concept trial with dasiglucagon, and secures DKK 560 million in additional investment 2019 Q3 Interim Report Copenhagen, November 14, 2019 – Zealand...
– Company stops further development of clinically symptomatic respiratory illness indication but continues development of RTB101 in other aging-related diseases, including Parkinson’s disease — — Company remains well funded with $117.3 million in...
A new University of Hawaiʻi Cancer Center coordinated liver cancer clinical trial opened in Hawaiʻi combining two different immunotherapy medications to combat the aggressive disease. The Phase II clinical trial is only available in Hawaiʻi, a state with one of the...
Seven Compelling Stories Spotlight the Benefits of Clinical Trial Participation, Access to Life-Saving Medical Advances, and Optimal Lung Cancer Care and Treatment Options WASHINGTON, Nov. 14, 2019 /PRNewswire/ — LUNGevity, the nation’s leading lung...
Email
Text